This suggests that part of Retatrutides effectiveness in improving cholesterol levels comes from its direct action on the liver, providing a clearer picture of how this promising new drug works
Noteworthy, new serious adverse event (AE) signals were identified, including hemorrhagic diarrhea (ROR: 3.69), hepatic pain (ROR: 4.20), abnormal hormone levels (ROR: 6.51), and pancreatic failure (ROR: 36.34) in subcutaneous semaglutide, and Dupuytrens contracture (ROR: 46.85) in oral semaglutide
The Association of Diabetes Care and Education Specialists (ADCES) and American Diabetes Association recommend rotating injection sites within the same anatomical region and spacing injections appropriately to avoid tissue damage
To validate our findings, we set out to replicate them in the real-world data of the All of Us Research Program
Laboratory in-vitro experimental use only